Spirometric definition of COPD: Exercise in futility or factual debate?

Thorax

Volumn 67, Issue 7, 2012, Pages 569-570

  Brusasco, Vito ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE PREDISPOSITION; EDITORIAL; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INTERMETHOD COMPARISON; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SMOKING HABIT; SPIROMETRY;

EID: 84862766300     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201720     Document Type: Editorial

References (21)

1. Global Strategy for the Diagnosis, Management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011. http://www.goldcopd.org/
2. National clinical guideline Centre. Chronic Obstructive Pulmonary Disease: Management Of Chronic Obstructive Pulmonary Disease In Adults In Primary And Secondary Care. London: National clinical guideline Centre, 2010. http://guidance.nice.org.uk/ CG101/Guidance/pdf/English
3. O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Resp J 2008;15(Suppl A):1A-8A.
4. Anon. Evaluation of impairment/disability secondary to respiratory disorders. American Thoracic Society. Am Rev Respir Dis 1986;133:1205-9.
5. Quanjer PH, Tammeling GJ, Cotes JE, et al. Standardized lung function testing. Eur Respir J 1993;6:1-99.
6. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.
7. Pauwels RA, Buist AS, Calverley PM, et al; GOLD Scientific committee. Global strategies for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
8. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20:1117-20.
9. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest 2007;131:349-55.
10. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008;63:1046-51.
11. Cerveri I, Corsico AG, Accordini S, et al. Underestimation of airflow obstruction among young adults using FEV FVC<70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008;63:1040-5.
12. Falaschetti E, Laiho J, Primatesta P, et al. Prediction equations for normal and low lung function from the health survey for England. Eur Respir J 2004;23:456-63.
13. Jordan RE, Miller MR, Lam KU, et al. Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the health survey for England. Thorax 2012;67:600-5.
14. Bakke PS, Rönmark E, Eagan T, et al. Recommendations for epidemiological studies on COPD. Eur Respir J 2011;38:1261-77.
15. Quanjer PH, Enright PL, Miller MR, et al. The need to change the method for defining mild airway obstruction. Eur Respir J 2011;37:720-2.
16. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988;43:265-7.
17. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J 2010;35:676-80.
18. Mannino DM, Doherty DE, Buist AS. Global Initiative on obstructive lung disease (GOLD) classification of lung disease and mortality: findings from the atherosclerosis risk in communities (ARIC) study. Respir Med 2006;100:115-22.
19. Mannino DM, Diaz-Guzman E. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Chest 2012;141:73-80.
20. Lamprecht B, Schirnhofer L, Kaiser B, et al. Subjects with discordant airways obstruction: lost between spirometric definitions of COPD. Pulm Med 2011;2011:780215.
21. Calverley PM, Kuna P, Monsó E, et al. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. Respir Med 2010;104:1858-68.